Consider This from NPR

How A Bankruptcy Deal Could Offer Clean Slate For Opioid Billionaires

Aug 30, 2021

Brian Mann, NPR's addiction correspondent with years of experience covering Purdue Pharma, delves into the complex saga surrounding the Sackler family and their role in the opioid crisis. He discusses how a federal bankruptcy ruling may allow the Sacklers to retain their fortunes while victims seek justice. Listeners learn about the aggressive marketing of OxyContin, the family’s philanthropic image amidst scandal, and the implications of legal immunity that could hinder accountability for their actions.

12:14

Creator website

Episode guests

Brian Mann

AI Chapters

Episode notes

Intro

3min

The Sacklers and the Opioid Crisis

3min

The Reckoning of a Philanthropic Dynasty Amidst Scandal

2min

Legal Immunity for Wealthy Families in Bankruptcy Proceedings

2min

Examining Accountability in the Sackler Settlement

4min

A federal bankruptcy judge says he'll rule Wednesday in the case of Purdue Pharma, makers of OxyContin. The company is owned by the Sackler family, who are at the center of a national reckoning over the deadly opioid epidemic.

NPR addiction correspondent Brian Mann has been covering the story of Purdue Pharma for years, and explains how the Sacklers may emerge from Purdue's bankruptcy proceedings with their personal fortunes in tact. Find more of Brian's reporting here or follow him on Twitter @BrianMannADK.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.